Processes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8580974
APP PUB NO 20110046397A1
SERIAL NO

12863213

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a new process for producing NEP inhibitors or prodrugs thereof, in particular NEP inhibitors comprising a γ-amino-δ-biphenyl-α-methylalkanoic acid, or acid ester, backbone. In detail, the new processes, according to the present invention, are ultimately related to the synthesis of intermediates to prepare the above NEP inhibitors, namely compounds according to formula (1), or salt thereof,

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS PHARMACEUTICALS CORPORATIONONE HEALTH PLAZA EAST HANOVER NJ 07936

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bappert, Erhard Basel, CH 18 94
Hook, David Rheinfelden, CH 23 203
Kaufmann, Daniel Bättwil, CH 22 112
Medlock, Jonathan Cambridge, GB 7 72
Napp, Matthias Lörrach, DE 11 168
Polleux, Philippe Riehen, CH 4 6
Riss, Bernhard Huningue, FR 10 171
Zanotti-Gerosa, Antonio Cambridge, GB 31 156

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 12, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00